PlainRecalls
FDA Devices Moderate Class II Ongoing

IBA Proton Therapy System - PROTEUS 235 - Designed to produce and deliver a proton beam for the treatment of patients with localized tumors and other conditions susceptible to treatment by radiation.

Reported: June 12, 2024 Initiated: May 10, 2024 #Z-1945-2024

Product Description

IBA Proton Therapy System - PROTEUS 235 - Designed to produce and deliver a proton beam for the treatment of patients with localized tumors and other conditions susceptible to treatment by radiation.

Reason for Recall

Irradiation is not interrupted when some C230 Accelerator Control Unit critical parameters are outside of the defined tolerances

Details

Units Affected
2 units
Distribution
Worldwide - US Nationwide distribution in the state of Virginia and the country of India.
Location
Ottignies-Louvain-La-Neuve, N/A

Frequently Asked Questions

What product was recalled?
IBA Proton Therapy System - PROTEUS 235 - Designed to produce and deliver a proton beam for the treatment of patients with localized tumors and other conditions susceptible to treatment by radiation.. Recalled by Ion Beam Applications S.A.. Units affected: 2 units.
Why was this product recalled?
Irradiation is not interrupted when some C230 Accelerator Control Unit critical parameters are outside of the defined tolerances
Which agency issued this recall?
This recall was issued by the FDA Devices on June 12, 2024. Severity: Moderate. Recall number: Z-1945-2024.